Monday, 19 October 2026European Markets

METABOLIC EXPLORER Stock 11.83% Up On Thursday

Loading stream...

(vianews) - the market ended the session with metabolic explorer (metex.pa) jumping 11.83% to €1.08 on thursday while cac 40 rose 0.28% to €7,381.78.

metabolic explorer's last close was €0.96, 80.91% under its 52-week high of €5.05.

about metabolic explorer

metabolic explorer s.a., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. the company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and l-valine. its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. the company was incorporated in 1999 and is based in saint-beauzire, france.

earnings per share

as for profitability, metabolic explorer has a trailing twelve months eps of €-0.78.

volatility

metabolic explorer's last week, last month's, and last quarter's current intraday variation average was a positive 0.95%, a negative 0.73%, and a positive 2.68%.

metabolic explorer's highest amplitude of average volatility was 3.72% (last week), 2.17% (last month), and 2.68% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, metabolic explorer's stock is considered to be oversold (<=20).

revenue growth

year-on-year quarterly revenue growth declined by 26.9%, now sitting on 228.15m for the twelve trailing months.

moving average

metabolic explorer's worth is below its 50-day moving average of €1.15 and way below its 200-day moving average of €1.59.

more news about metabolic explorer (metex.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Sovereign, Local and Open AI: Infrastructure and Applied Intelligence Scale Up While Frontier-Lab Safety Scrutiny Grows
AI is shifting from cloud-rented models toward locally run, owned and open intelligence. ASUS/NVIDIA RTX Spark laptops pair with Nous Research's Hermes and ComfyUI, and Microsoft pushes hybrid local/cloud Windows. Cisco, NVIDIA and Marvell build open high-bandwidth AI infrastructure, and Hesai supplies real-world data for physical AI. In finance and commerce, Intuit, Zeta, Parloa/TELUS Digital and Snipp embed agentic AI into trusted financial and customer workflows, while OpenAI's math breakthroughs, its security disclosures and an executive's departure from its safety role keep safety and governance scrutiny high.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,397 source documents archived
Query this data → isubstrate.com